{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T16:56:29Z","timestamp":1758905789215},"reference-count":40,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2015,10,14]],"date-time":"2015-10-14T00:00:00Z","timestamp":1444780800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0140345","type":"journal-article","created":{"date-parts":[[2015,10,14]],"date-time":"2015-10-14T18:14:46Z","timestamp":1444846486000},"page":"e0140345","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":8,"title":["FetA Antibodies Induced by an Outer Membrane Vesicle Vaccine Derived from a Serogroup B Meningococcal Isolate with Constitutive FetA Expression"],"prefix":"10.1371","volume":"10","author":[{"given":"Holly","family":"Sanders","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gunnstein","family":"Norheim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannah","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Dold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Vipond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremy P.","family":"Derrick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew J.","family":"Pollard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin C. J.","family":"Maiden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian M.","family":"Feavers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2015,10,14]]},"reference":[{"key":"ref1","article-title":"Annual Epidemiological Report 2012: Reporting on 2010 surveillance data and 2011 epidemic intelligence data","year":"2013"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"12493","DOI":"10.1021\/bi800431c","article-title":"The conformational properties of methyl alpha-(2,8)-di\/trisialosides and their N-acyl analogues: implications for anti-Neisseria meningitidis B vaccine design","volume":"47","author":"AB Yongye","year":"2008","journal-title":"Biochemistry"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0140-6736(83)90340-9","article-title":"Antigenic similarities between brain components and bacteria causing meningitis. Implications for vaccine development and pathogenesis","volume":"2","author":"J Finne","year":"1983","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"290","DOI":"10.4161\/hv.4513","article-title":"Strategies for development of universal vaccines against meningococcal serogroup B disease: the most promising options and the challenges evaluating them","volume":"3","author":"J Holst","year":"2007","journal-title":"Hum Vaccin"},{"key":"ref5","first-page":"195","article-title":"Vaccine against group B Neisseria meningitidis: protection trial and mass vaccination results in Cuba","volume":"14","author":"GV Sierra","year":"1991","journal-title":"NIPH Ann"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/0140-6736(92)93086-3","article-title":"Protective efficacy of a serogroup B meningococcal vaccine in Sao Paulo, Brazil","volume":"340","author":"JC de Moraes","year":"1992","journal-title":"Lancet"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"7100","DOI":"10.1016\/j.vaccine.2011.06.120","article-title":"Effectiveness of a vaccination programme for an epidemic of meningococcal B in New Zealand","volume":"29","author":"R Arnold","year":"2011","journal-title":"Vaccine"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/0140-6736(91)91961-S","article-title":"Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway","volume":"338","author":"G Bjune","year":"1991","journal-title":"Lancet"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"5059","DOI":"10.1016\/j.vaccine.2012.05.051","article-title":"Evolution of immune response against Neisseria meningitidis B:14:P1.7,16 before and after the outer membrane vesicle vaccine MenBvac","volume":"30","author":"F Caron","year":"2012","journal-title":"Vaccine"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"4642","DOI":"10.1128\/IAI.63.12.4642-4652.1995","article-title":"Human antibody responses to meningococcal outer membrane antigens after three doses of the Norwegian group B meningococcal vaccine","volume":"63","author":"E Rosenqvist","year":"1995","journal-title":"Infect Immun"},{"issue":"Suppl 2","key":"ref11","doi-asserted-by":"crossref","first-page":"B42","DOI":"10.1016\/j.vaccine.2009.05.001","article-title":"Meningococcal protein antigens and vaccines","volume":"27","author":"IM Feavers","year":"2009","journal-title":"Vaccine"},{"issue":"Suppl 2","key":"ref12","doi-asserted-by":"crossref","first-page":"B87","DOI":"10.1016\/j.vaccine.2012.01.033","article-title":"The new multicomponent vaccine against meningococcal serogroup B, 4CMenB: immunological, functional and structural characterization of the antigens","volume":"30","author":"D Serruto","year":"2012","journal-title":"Vaccine"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1016\/j.vaccine.2006.09.025","article-title":"Immunogenicity of a combination vaccine containing pneumococcal conjugates and meningococcal PorA OMVs","volume":"25","author":"GP van den Dobbelsteen","year":"2007","journal-title":"Vaccine"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1016\/S0264-410X(99)00044-4","article-title":"Immunogenicity and reactogenicity in UK infants of a novel meningococcal vesicle vaccine containing multiple class 1 (PorA) outer membrane proteins","volume":"17","author":"K Cartwright","year":"1999","journal-title":"Vaccine"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"5434","DOI":"10.1128\/IAI.00411-07","article-title":"Additive and synergistic bactericidal activity of antibodies directed against minor outer membrane proteins of Neisseria meningitidis","volume":"75","author":"VE Weynants","year":"2007","journal-title":"Infect Immun"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1086\/528994","article-title":"Complement-dependent synergistic bactericidal activity of antibodies against factor H-binding protein, a sparsely distributed meningococcal vaccine antigen","volume":"197","author":"JA Welsch","year":"2008","journal-title":"J Infect Dis"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"4217","DOI":"10.1128\/IAI.72.7.4217-4223.2004","article-title":"NadA diversity and carriage in Neisseria meningitidis","volume":"72","author":"M Comanducci","year":"2004","journal-title":"Infect Immun"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"e56746","DOI":"10.1371\/journal.pone.0056746","article-title":"Use of a molecular decoy to segregate transport from antigenicity in the FrpB iron transporter from Neisseria meningitidis","volume":"8","author":"M Saleem","year":"2013","journal-title":"PLoS One"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"6811","DOI":"10.1073\/pnas.0912115107","article-title":"Structural basis for solute transport, nucleotide regulation, and immunological recognition of Neisseria meningitidis PorB","volume":"107","author":"M Tanabe","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0022-1759(00)00245-3","article-title":"IgG antibody levels to meningococcal porins in patient sera: comparison of immunoblotting and ELISA measurements","volume":"244","author":"E Wedege","year":"2000","journal-title":"J Immunol Methods"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1099\/00222615-32-4-275","article-title":"Immunogenicity and cross-reactivity of the 70-Kda iron-regulated protein of Neisseria meningitidis in man and animals","volume":"32","author":"DA Ala'Aldeen","year":"1990","journal-title":"J Med Microbiol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1574-6976.2006.00056.x","article-title":"Multilocus sequence typing for global surveillance of meningococcal disease","volume":"31","author":"C Brehony","year":"2007","journal-title":"FEMS Microbiol Rev"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"15082","DOI":"10.1073\/pnas.0712019105","article-title":"Role of selection in the emergence of lineages and the evolution of virulence in Neisseria meningitidis","volume":"105","author":"CO Buckee","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"e45349","DOI":"10.1371\/journal.pone.0045349","article-title":"Persistence of hyperinvasive meningococcal strain types during global spread as recorded in the PubMLST database","volume":"7","author":"ER Watkins","year":"2012","journal-title":"PLoS One"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"5955","DOI":"10.1128\/IAI.72.10.5955-5962.2004","article-title":"Distribution of surface protein variants among hyperinvasive meningococci: implications for vaccine design","volume":"72","author":"R Urwin","year":"2004","journal-title":"Infect Immun"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/0264-410X(94)90314-X","article-title":"Vaccine potential of meningococcal FrpB: studies on surface exposure and functional attributes of common epitopes","volume":"12","author":"DA Ala'Aldeen","year":"1994","journal-title":"Vaccine"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"80","DOI":"10.4161\/hv.1.2.1651","article-title":"Characterization of the protein content of a meningococcal outer membrane vesicle vaccine by polyacrylamide gel electrophoresis and mass spectrometry","volume":"1","author":"C Vipond","year":"2005","journal-title":"Hum Vaccin"},{"key":"ref28","unstructured":"Thompson EA (2001) Antigenic variation in the potential meningococcal vaccine candidate FetA. Oxford: PhD Thesis, University of Oxford."},{"key":"ref29","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1128\/IAI.64.7.2745-2751.1996","article-title":"Specificity of human bactericidal antibodies against PorA P1.7,16 induced with a hexavalent meningococcal outer membrane vesicle vaccine","volume":"64","author":"ER van der Voort","year":"1996","journal-title":"Infect Immun"},{"key":"ref30","first-page":"81","article-title":"Outer membrane protein vesicle vaccines for meningococcal disease","volume":"66","author":"CE Frasch","year":"2001","journal-title":"Methods Mol Med"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1365-3083.2012.02709.x","article-title":"An outer membrane vesicle vaccine for prevention of serogroup A and W-135 meningococcal disease in the African meningitis belt","volume":"76","author":"G Norheim","year":"2012","journal-title":"Scand J Immunol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1107\/S1744309111056028","article-title":"Refolding, purification and crystallization of the FrpB outer membrane iron transporter from Neisseria meningitidis","volume":"68","author":"M Saleem","year":"2012","journal-title":"Acta Crystallogr Sect F Struct Biol Cryst Commun"},{"key":"ref33","first-page":"91","article-title":"Neisseria meningitidis: Advanced Methods and Protocols","author":"M Saleem","year":"2012"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1128\/CDLI.12.8.970-976.2005","article-title":"Interlaboratory standardization of the measurement of serum bactericidal activity by using human complement against meningococcal serogroup b, strain 44\/76-SL, before and after vaccination with the Norwegian MenBvac outer membrane vesicle vaccine","volume":"12","author":"R Borrow","year":"2005","journal-title":"Clin Diagn Lab Immunol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/S0264-410X(02)00591-1","article-title":"Serum bactericidal activity correlates with the vaccine efficacy of outer membrane vesicle vaccines against Neisseria meningitidis serogroup B disease","volume":"21","author":"J Holst","year":"2003","journal-title":"Vaccine"},{"issue":"Suppl 2","key":"ref36","doi-asserted-by":"crossref","first-page":"B112","DOI":"10.1016\/j.vaccine.2009.04.065","article-title":"Bactericidal antibody is the immunologic surrogate of protection against meningococcal disease","volume":"27","author":"CE Frasch","year":"2009","journal-title":"Vaccine"},{"issue":"Suppl 2","key":"ref37","doi-asserted-by":"crossref","first-page":"B10","DOI":"10.1016\/j.vaccine.2011.12.060","article-title":"History of meningococcal vaccines and their serological correlates of protection","volume":"30","author":"C Vipond","year":"2012","journal-title":"Vaccine"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1128\/IAI.66.7.3223-3231.1998","article-title":"Immune responses against major outer membrane antigens of Neisseria meningitidis in vaccinees and controls who contracted meningococcal disease during the Norwegian serogroup B protection trial","volume":"66","author":"E Wedege","year":"1998","journal-title":"Infect Immun"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1128\/CVI.00039-07","article-title":"Functional and specific antibody responses in adult volunteers in new zealand who were given one of two different meningococcal serogroup B outer membrane vesicle vaccines","volume":"14","author":"E Wedege","year":"2007","journal-title":"Clin Vaccine Immunol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.vaccine.2006.07.016","article-title":"Shielding of immunogenic domains in Neisseria meningitidis FrpB (FetA) by the major variable region","volume":"25","author":"J Kortekaas","year":"2007","journal-title":"Vaccine"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0140345","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,9]],"date-time":"2020-09-09T19:51:00Z","timestamp":1599681060000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0140345"}},"subtitle":[],"editor":[{"given":"Daniela Flavia","family":"Hozbor","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,10,14]]},"references-count":40,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2015,10,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0140345","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,14]]}}}